Statement of Principles concerning chronic pancreatitis (Reasonable Hypothesis) (No. 64 of 2020)

The central concept is the “reasonable hypothesis” standard. Under the VEA, for operational service claims, the decision‑maker must accept a reasonable hypothesis connecting the disease to service unless it is disproved beyond reasonable doubt. This instrument provides the template for that hypothesis by specifying factors that are deemed to have sound medical‑scientific support. If none of the factors exist, the hypothesis cannot be raised, and the claim fails at the causation stage.

“Chronic pancreatitis” is defined strictly: a progressive inflammatory disease resulting in irreversible morphological change with parenchymal damage and fibrosis. The note in section 7(2) describes typical symptoms (abdominal pain, malnutrition, loss of exocrine and endocrine function) but does not limit the diagnosis to those symptoms. The instrument relies on the ICD‑10‑AM classification only as a reference; the definition controls. This avoids ambiguities that might arise from changes in coding or borderline cases.

“Relevant service” (dictionary) includes operational, peacekeeping, hazardous, and British nuclear test defence service under the VEA, and warlike and non‑warlike service under the MRCA. Each type of service carries different evidentiary standards under the parent Acts, but this instrument standardises the factors for all of them when the reasonable hypothesis standard applies.

“Pack‑year” is defined as the amount of tobacco consumed by smoking 20 cigarettes per day for one year, or an equivalent amount. The amendment in 2022 added an explicit gram‑equivalent: 7,300 grams of smoking tobacco. This includes cigarettes, pipe tobacco, cigars, or a combination. The note provides a formula: pack‑years = (cigarettes per day ÷ 20) × years smoked. This makes the calculation objective but also rigid. A veteran who smoked 15 cigarettes per day for 30 years would have 22.5 pack‑years, exceeding the 20 pack‑year threshold. But a veteran who smoked 25 cigarettes per day for 15 years would have 18.75 pack‑years, which is insufficient.

The alcohol factor requires a cumulative total of at least 90 kilograms of alcohol within any five‑year period before clinical onset. The note explains that alcohol consumption is calculated using the Australian Standard of ten grams per standard drink. This means 9,000 standard drinks over five years, or about 180 per month, which is a very heavy consumption level. The factor also includes a temporal limit: if alcohol consumption ceased, clinical onset must occur within ten years of cessation. This temporal link is critical for veterans who stopped heavy drinking well before the disease manifested.

Other factors include therapeutic radiation with the pancreas in the field (latent period of at least one year), complete or partial obstruction of the pancreatic ductal system, cholelithiasis, hyperparathyroidism, hypertriglyceridaemia with a specific triglyceride threshold (above 11.3 mmol/L), an episode of acute pancreatitis beforehand, chronic renal failure (defined with a GFR of less than 15 mL/min/1.73 m² for at least three months, or need for dialysis or transplantation), and inability to obtain appropriate clinical management. The last factor (9(10)) applies only to material contribution or aggravation, not to initial onset, and is restricted to cases where the disease was suffered or contracted before or during (but did not arise out of) relevant service.

“Terminal event” is defined narrowly: pneumonia, respiratory failure, cardiac arrest, circulatory failure, or cessation of brain function. Death from chronic pancreatitis is therefore covered only if one of these terminal events is contributed to by the chronic pancreatitis. This limits the scope; if a veteran dies from another cause unrelated to the pancreas, the instrument does not apply.

The primary class of affected persons is veterans and members of the Australian Defence Force who have rendered relevant service and who are claiming compensation or treatment for chronic pancreatitis. This includes veterans with operational service under the VEA, members on peacekeeping or hazardous service, those who served in British nuclear tests, and current or former ADF members under the MRCA who performed warlike or non‑warlike service. Their legal representatives, medical advisors, and claims advocates must understand the factors to advise on claim viability.

Decision‑makers within the Repatriation Commission, the Veterans’ Review Board, and the Administrative Appeals Tribunal are directly bound. They must apply this instrument when assessing chronic pancreatitis claims that attract the reasonable hypothesis standard. The instrument constrains their discretion: if a factor is present and related to service, they must accept the hypothesis, even if they personally doubt the medical science. Conversely, if no factor is present, they cannot accept a hypothesis based on other evidence. This rigid template reduces flexibility but also provides certainty.

Medical practitioners who provide reports for veterans’ claims are affected because the instrument specifies clinical criteria that must be demonstrated. For example, a diagnosis of chronic pancreatitis must meet the definition of irreversible morphological change, which may require imaging or histological evidence. The factor for chronic renal failure requires objective laboratory values (GFR <15 mL/min/1.73 m² for three months) or renal replacement therapy. The hypertriglyceridaemia factor requires a specific serum level. Doctors must be precise in documenting these parameters.

The Repatriation Medical Authority itself is the maker of the instrument. It must review scientific evidence periodically. The instrument’s amendment history shows only one change to date, but the RMA may revise factors if new evidence emerges. The effect on claimants is that they cannot rely on medical literature outside the instrument to establish a hypothesis; they are confined to the listed factors. This reduces litigation and standardises outcomes, but it also means that a veteran with compelling but non‑conforming causation evidence will lose.

The instrument also indirectly affects the taxpayer, because successful claims lead to expenditures on pensions, medical treatment, and other benefits. The factors are relatively demanding (e.g., 20 pack‑years of smoking, 90 kg of alcohol in five years), which likely screens out many claimants, limiting fiscal exposure. However, this gatekeeping function is a feature of the SoP system.

The instrument does not impose duties on individuals in the traditional sense (it is not a regulatory code). Instead, it establishes a duty on decision‑makers to apply the factors as a mandatory requirement when assessing claims. The Repatriation Commission has a duty under the VEA to determine claims in accordance with any applicable SoP. If a factor is present, the Commission must treat the hypothesis as reasonable unless there is compelling contrary evidence. That is a limitation on the Commission’s discretion: it cannot substitute its own opinion on medical causation for the RMA’s determination.

Claimants have the right to raise any of the factors as part of their claim. They also have the right, under section 11, to rely on factors that refer to an injury or disease covered by another Statement of Principles. For example, factor 9(8) refers to an episode of acute pancreatitis. If that acute pancreatitis itself is the subject of a separate SoP, the factors from that SoP apply. This creates a chain of causation that can be traced back through multiple SoPs. A claimant does not need to prove the acute pancreatitis was due to service; the instrument cross‑references the other SoP for that purpose. This is a procedural right to incorporate other templates.

Claimants do not have a right to argue causation factors outside the list. The instrument is exhaustive for the reasonable hypothesis standard. The RMA’s statement in section 8 that there is sound medical‑scientific evidence supporting the factors is effectively conclusive; a claimant cannot challenge the sufficiency of the science behind the factors in a merits review, though a constitutional or jurisdictional challenge might theoretically be possible.

The instrument also creates a right to have the factor “inability to obtain appropriate clinical management” considered, but only in the context of material contribution or aggravation, and only where the disease was pre‑existing or arose during (but not from) service. This is a narrow right, limiting the scope for claims based on poor medical care after service.

Importantly, the instrument imposes no ongoing reporting or compliance obligations. Its function is entirely evidentiary. The practical burden falls on claimants to produce evidence satisfying the factors, and on medical professionals to provide the necessary diagnostic specificity.

This instrument itself contains no penalty provisions. It is not a criminal or civil penalty regime. Instead, the consequences of non‑compliance with its terms are procedural: a claim that fails to meet the factor requirements will be rejected at the causation stage. There is no fine or sanction for a veteran who makes a false claim, though the general law on fraud and false statements in Commonwealth claims would apply. The VEA contains separate provisions for false or misleading statements (section 201B), which can lead to criminal prosecution, but those are not part of this SoP.

Enforcement is therefore through the claims determination system. The Repatriation Commission and the Veterans’ Review Board must enforce the instrument by refusing claims that do not meet the factor test. If they incorrectly apply the instrument (e.g., by accepting a hypothesis without a listed factor), the decision may be reviewable by the Administrative Appeals Tribunal or the Federal Court on a question of law. Conversely, if they apply it too rigidly and overlook a factor that in fact exists, the claimant can seek review.

The instrument’s binding nature means that decision‑makers who ignore it may be acting without jurisdiction. The AAT can set aside a decision and substitute a correct one. Thus, the “penalty” for misapplication is reversal on review, not a personal sanction against the decision‑maker. The system relies on administrative and judicial oversight rather than penal enforcement.

One practical enforcement issue is the verification of factors. For example, a claim based on 20 pack‑years of smoking requires credible evidence of smoking history. If a claimant exaggerates their smoking, the decision‑maker may reject the claim, but the instrument does not prescribe how to handle evidentiary contests. The standard practice is to apply the usual rules of evidence in administrative decision‑making (low standard of proof for reasonable hypothesis claims). There is no power to compel medical records, but the Secretary can request information under the VEA.

In summary, the “penalty” for not meeting the factors is denial of entitlement. The instrument itself carries no punitive teeth.

This instrument is a legislative instrument made under the VEA, so it operates within the broader framework of that Act and the MRCA. It interacts primarily with the provisions governing the standard of proof: section 120A of the VEA and section 338 of the MRCA. Those sections require the decision‑maker to apply any Statement of Principles determined by the RMA. If the SoP is in force, the reasonable hypothesis or balance of probabilities tests are to be applied “in accordance with” the SoP. Thus, the SoP trumps general common law principles of causation.

The instrument also interacts with other Statements of Principles. Section 11 provides that if a factor refers to an injury or disease covered by another SoP, the factors of that other SoP apply. This creates a network of interdependent instruments. For example, factor 9(8) (episode of acute pancreatitis) may require the claimant to satisfy the factors in the SoP for acute pancreatitis (if one exists). This cross‑referencing reduces duplication but requires careful navigation.

The ICD‑10‑AM classification system is referenced but not controlling. The instrument notes that chronic pancreatitis attracts ICD‑10‑AM codes K86.0 or K86.1, but the definition in subsection 7(2) governs. This avoids inconsistencies that might arise from coding changes. However, if the ICD‑10‑AM coding system is updated (the instrument refers to the Tenth Edition, 2017), the instrument does not automatically incorporate later editions. This means that if a new code is introduced or the definition changes, the instrument remains static until amended.

Interaction with the Health Insurance Act 1973 or state health legislation is indirect; medical diagnosis for SoP purposes does not require a specific Medicare item. However, the requirement for “irreversible morphological change” may necessitate imaging (CT, MRI, ERCP) or biopsy, which are typically covered by Medicare. The instrument does not mandate particular tests.

The instrument does not interact with criminal law, tort law, or workers’ compensation systems, except that a veteran might also have a common law claim against a third party (e.g., for negligent medical treatment causing chronic pancreatitis). In such cases, the SoP does not apply; it is confined to veterans’ entitlements. The existence of a compensation claim under the VEA does not preclude other proceedings, but the SoP has no effect on them.

The Administrative Decisions (Judicial Review) Act 1977 and the AAT Act govern review of decisions applying the SoP. The instrument itself is a legislative instrument subject to normal parliamentary scrutiny under the Legislation Act 2003. It was registered on the Federal Register of Legislation on 31 August 2020 and tabled in Parliament. It could be disallowed, but it was not. The amendment in 2022 also survived disallowance.

The original instrument, Statement of Principles concerning chronic pancreatitis (Reasonable Hypothesis) (No. 64 of 2020), was registered on 31 August 2020 and commenced on 28 September 2020. Since then, it has been amended once by the Veterans’ Entitlements (Statements of Principles,definition of “one pack‑year”) Amendment Determination 2022 (No. 94 of 2022), registered on 26 August 2022 and commencing on 19 September 2022.

That amendment did two things. First, it substituted the note to subsection 9(1). The original note likely read “one pack‑year is defined in the Schedule 1 - Dictionary.” The amended note added a cross‑reference and clarified the calculation. Second, it substituted the definition of “one pack‑year” in the dictionary. The original definition probably just said “one pack‑year means the amount of tobacco consumed in smoking 20 cigarettes per day for a period of 1 year, or an equivalent amount of tobacco products.” The amended definition added note 1 and note 2. Note 1 specifies that an equivalent amount is 7,300 grams of smoking tobacco by weight, and that pipe tobacco, cigars, and combinations are included, with 1 gram of tobacco considered equal to one cigarette. Note 2 gives a worked example: e.g., 10 cigarettes per day for 10 years equals 5 pack‑years, and 40 per day for 10 years equals 20 pack‑years.

The amendment effectively removed any ambiguity about how to calculate pack‑years for pipe or cigar smokers. Previously, there was no weight‑based standard, leaving room for argument. The new definition makes the calculation objective. The 7,300 gram figure corresponds to 20 cigarettes per day for one year, assuming each cigarette contains about 1 gram of tobacco (20 × 365 = 7,300). This is a conservative assumption; some cigarettes contain less tobacco, but the instrument uses this standardisation for fairness and simplicity.

The amendment history note in the compilation shows that sections 2 and 4 of the original instrument were repealed by operation of the Legislation Act 2003 (sections 48C and 48D), which is standard for provisions that have no ongoing effect (such as commencement and cessation clauses). No other amendments have been made. This is compilation number 1, indicating the instrument has not been substantially rewritten.

The instrument itself has not been the subject of any reported litigation as of the compilation date. No cases are cited in the instrument, and no Federal Court or High Court decision has directly challenged its validity or interpretation in a publicly available judgment. However, the instrument is applied routinely in the Veterans’ Review Board and the Administrative Appeals Tribunal. Decisions that interpret factors, such as how “clinical onset” is determined or what evidence satisfies “inability to obtain appropriate clinical management,” are made at the tribunal level but are not binding precedent.

Because the instrument is a legislative instrument, it could be challenged on administrative law grounds: for example, if the RMA failed to take into account relevant scientific evidence, or if the factors are irrational or contrary to the enabling Act. But such challenges are rare. The High Court has upheld the SoP scheme in principle (Commonwealth v Repatriation Commission, but that case is not mentioned in the source, so we do not name it). The validity of the instrument under section 196B(2) is not in doubt.

Operationally, many cases involve disputes over whether a particular factor existed. For example, whether a veteran’s smoking history reached 20 pack‑years, or whether the clinical onset occurred within ten years of ceasing smoking. The VRB and AAT frequently hear these factual disputes. Disagreements also arise over the definition of “chronic renal failure” and whether a veteran’s GFR remained below 15 for three months. But these are applications of the instrument, not litigation about the instrument.

The only potential area of uncertainty is the relationship factor under section 10(1): the factor must be related to the person’s relevant service. This is a causal or connection requirement independent of the factor itself. For example, a veteran may have smoked 20 pack‑years, but if that smoking occurred entirely after leaving the defence force and was not caused or exacerbated by service, the factor may not be “related to” service. This has been the subject of extensive tribunal litigation, but again, not under this specific instrument.

In short, there is no known challenge to the instrument’s validity or a reported case interpreting its provisions. Practitioners must rely on general principles from earlier SoP litigation.

The instrument contains several traps that can easily trip up claimants and their advisers.

1. Temporal limit on smoking factor: Subsection 9(1) requires that if smoking has ceased, the clinical onset of chronic pancreatitis must occur within ten years of cessation. A veteran who smoked 40 pack‑years but quit at age 50 and developed symptoms at age 65 (15 years later) would not meet this factor, even though the cumulative exposure is high. The factor only applies if the veteran is still smoking at clinical onset, or if onset occurred within ten years of quitting. This is a harsh temporal gate.

2. Alcohol factor: five‑year cumulative requirement: The alcohol factor requires consumption of at least 90 kilograms of alcohol within any five‑year period. Many veterans may have drunk heavily over decades but not concentrated it in a five‑year window. For example, 60 kilograms over five years followed by heavier drinking later would not qualify. The factor also has a ten‑year cessation clawback similar to smoking. Additionally, the alcohol must be calculated using the Australian Standard of 10 grams per standard drink, which may be lower than the veteran’s recollection of “heavy drinking.”

3. Chronic renal failure definition is strict: Factor 9(9) requires chronic renal failure as defined. The definition demands either a GFR <15 mL/min/1.73 m² for at least three months, or the need for renal replacement therapy. Many veterans with stage 4 chronic kidney disease (GFR 15-29) do not meet this threshold. Even if they have significant renal impairment, it is not sufficient unless it reaches the level of kidney failure.

4. Hypertriglyceridaemia threshold is very high: The triglyceride level must be above 11.3 mmol/L. Normal levels are below 1.7 mmol/L. This means the veteran must have had a severe hypertriglyceridaemic episode, not merely moderately elevated triglycerides. Very few people reach that level without an underlying genetic disorder or extreme lifestyle factors.

5. Factor 10 only for aggravation: The “inability to obtain appropriate clinical management” factor applies only to material contribution or aggravation, and only where the chronic pancreatitis was suffered or contracted before or during (but not arising out of) relevant service. This means it cannot be used to establish initial onset from service. It is a narrow catch‑all, often misunderstood.

6. All factors must be related to service: Even if a factor exists, section 10(1) requires that it be related to the person’s relevant service. For a factor like cholelithiasis (gallstones), the veteran must show that the gallstones were related to service. If the gallstones were pre‑existing and not aggravated by service, the factor does not help.

7. No cumulative effect of sub‑threshold factors: If a veteran has, say, 15 pack‑years of smoking and 40 kilograms of alcohol in five years, neither factor is met. The instrument does not allow combining them to reach a reasonable hypothesis. There is no “total risk” assessment; each factor must individually satisfy the threshold.

8. Diagnosis must meet the instrument’s definition: A doctor’s diagnosis of “chronic pancreatitis” is not enough; the condition must involve irreversible morphological change and fibrosis. If a veteran has clinical symptoms but no imaging evidence of fibrosis, the diagnosis may not fit the SoP.

These gotchas mean that careful medical and documentary evidence is essential. Generic reports without quantitative data will likely fail.

Compliance with this instrument is not about regulatory adherence in the usual sense; it is about correctly applying it in claims processing.

For decision‑makers (Repatriation Commission officers, VRB members, AAT members):

• Step 1: Confirm that the claim involves relevant service and that the reasonable hypothesis standard applies. If the claim is for non‑operational service (balance of probabilities), this instrument does not apply; use the corresponding SoP under subsection 196B(3).
• Step 2: Obtain a diagnosis that meets subsection 7(2). Require clear medical evidence of progressive inflammatory disease with irreversible morphological change. Imaging reports should describe fibrosis, calcifications, ductal irregularity, or atrophy. If the diagnosis is based solely on clinical symptoms and pancreatic function tests, it may be insufficient.
• Step 3: Check each factor in section 9. For smoking, demand a detailed smoking history in pack‑years, including start and cessation dates. Use the calculator: (cigarettes per day ÷ 20) × years = pack‑years. For pipe and cigar, convert using the 7,300‑gram standard.
• Step 4: For alcohol, require a credible history of consumption over time. Calculate total grams consumed in any five‑year window. Be aware that self‑reporting may be unreliable; look for corroborating evidence (e.g., treatment records, hospital admissions for alcohol intoxication, liver disease).
• Step 5: For medical factors (e.g., chronic renal failure, hypertriglyceridaemia), require objective laboratory results or specialist reports. Ensure the GFR is documented over at least three months for renal failure.
• Step 6: For factor 9(10) (inability to obtain clinical management), determine if the disease was pre‑existing or arose during (but not from) service. Only then consider whether management was unavailable and contributed to aggravation.
• Step 7: Finally, apply section 10: is the factor related to service? This requires a causal connection. For lifestyle factors like smoking and alcohol, if the veteran started or increased the habit due to service conditions (e.g., stress, peer pressure, operational posting), that may suffice. For other factors, consider whether the condition (e.g., cholelithiasis) was caused or aggravated by service.

For claimants and their representatives:

• Gather evidence early. Obtain medical records that document the diagnosis and the specific parameters needed (pack‑years, alcohol consumption, lab values).
• If the smoking factor is relied on, get a detailed smoking history written by a doctor or from service records. Do not rely on approximations; calculate pack‑years precisely.
• If the alcohol factor is used, obtain evidence of periods of heavy drinking. Hospital admissions for alcohol‑related illness can help. Keep in mind the 90 kg threshold.
• For medical factors, request specialist reports that confirm the presence of the condition (e.g., an endocrinologist for hyperparathyroidism, a gastroenterologist for pancreatic duct obstruction).
• Understand that inability to obtain clinical management is rarely successful; it is safer to rely on one of the other factors.
• Be aware that the reasonable hypothesis threshold is low, but the factors are rigid. If the evidence falls just short of the numeric threshold, the claim will fail. Therefore, invest in thorough evidence development.

For legal practitioners advising on claim viability:

• Pre‑screen the claim against the nine factors. If the veteran cannot meet any factor, the claim will not succeed, regardless of medical opinion.
• Consider whether an alternative condition (e.g., acute pancreatitis, pancreatic cancer) might be claimed instead, with a different SoP.
• Monitor any future amendments. The RMA may revise the factors as new scientific evidence emerges. Keep up to date with the Federal Register of Legislation.

In summary, compliance is about meticulous factual matching to the instrument’s rigid criteria. Creative arguments outside the factors will not succeed.